Exploitation of the interaction of measles virus fusogenic envelope proteins with the surface receptor CD46 on human cells for microcell-mediated chromosome transfer

BMC Biotechnology

Volumn 10, Issue , 2010, Pages

  Katoh, Motonobu ^a,b   Kazuki, Yasuhiro ^b,c,d   Kazuki, Kanako ^c   Kajitani, Naoyo ^c   Takiguchi, Masato ^c   Nakayama, Yuji ^b   Nakamura, Takafumi ^d,e   Oshimura, Mitsuo ^b,c,d  

^a TOTTORI UNIVERSITY   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

^c TOTTORI UNIVERSITY   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL LINES; CELL SURFACE EXPRESSION; CELL TYPES; CHO CELL; CHROMOSOME TRANSFER; ECTOPIC EXPRESSIONS; ENVELOPE PROTEINS; FIBROSARCOMA CELLS; FISH ANALYSIS; FUNCTIONAL EXPRESSION; FUSION PROTOCOL; GENE FUNCTION; GENES ENCODING; GENETIC STUDIES; HT-1080; HT-1080 CELLS; HUMAN ARTIFICIAL CHROMOSOMES; HUMAN CELLS; LOW LEVEL; MAXIMUM EFFICIENCY; MEASLES VIRUS; MESENCHYMAL STEM CELL; MICRO CELL; MIXED CULTURES; RESISTANT CELLS; SELECTION MARKER; STABLE CLONES; SURFACE RECEPTORS; TRANSFECTANTS;

ANIMAL CELL CULTURE; CHROMOSOMES; GENE EXPRESSION; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; PROTEINS; STEM CELLS; TISSUE; VIRUSES;

CELL CULTURE;

BLASTICIDIN S; CELL SURFACE RECEPTOR; HEMAGGLUTININ; HYBRID PROTEIN; MEMBRANE COFACTOR PROTEIN; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ARTICLE; ARTIFICIAL CHROMOSOME; CANCER CELL CULTURE; CELL CULTURE; CELL IMMORTALIZATION; CHO CELL; CLONE; CONTROLLED STUDY; FEASIBILITY STUDY; FIBROBLAST; FIBROSARCOMA; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FUNCTION; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MARKER GENE; MEASLES VIRUS; MESENCHYMAL STEM CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SYNCYTIUM; TARGETED GENE REPAIR; VIRUS STRAIN; ANIMAL; CELL FUSION; CHEMISTRY; CRICETULUS; GENE VECTOR; HAMSTER; METHODOLOGY; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD46; CELL FUSION; CELL LINE, TUMOR; CHO CELLS; CHROMOSOMES, ARTIFICIAL, HUMAN; CRICETINAE; CRICETULUS; GENETIC VECTORS; HUMANS; MEASLES VIRUS; VIRAL ENVELOPE PROTEINS;

EID: 77951797214     PISSN: None     EISSN: 14726750     Source Type: Journal    
DOI: 10.1186/1472-6750-10-37     Document Type: Article

References (34)

1. Meaburn KJ, Parris CN, Bridger JM. The manipulation of chromosomes by mankind: the uses of microcell-mediated chromosome transfer. Chromosoma 2005, 114:263-274. 10.1007/s00412-005-0014-8, 16133353.
2. Oshimura M, Katoh M. Transfer of human artificial chromosome vectors into stem cells. Reprod Biomed Online 2008, 16:57-69.
3. Rutsch F, Gailus S, Miousse IR, Suormala T, Sagne C, Toliat MR, Nürnberg G, Wittkampf T, Buers I, Sharifi A, Stucki M, Becker C, Baumgartner M, Robenek H, Marquardt T, Höhne W, Gasnier B, Rosenblatt DS, Fowler B, Nürnberg P. Identification of a putative lysosomal cobalamin exporter altered in the cblF defect of vitamin B-12 metabolism. Nat Genet 2009, 41:234-239. 10.1038/ng.294, 19136951.
4. Oshimura M, Barrett JC. Role of telomerase repressors. Eur J Cancer 1997, 33:710-715. 10.1016/S0959-8049(97)00090-7, 9282109.
5. Quaye L, Dafou D, Ramus SJ, Song HL, Maharaj AG, Notaridou M, Hogdall E, Kjaer SK, Christensen L, Hogdall C, et al. Functional complementation studies identify candidate genes and common genetic variants associated with ovarian cancer survival. Hum Mol Genet 2009, 18:1869-1878. 10.1093/hmg/ddp107, 19270026.
6. Haugen AC, Goel A, Yamada K, Marra G, Nguyen TP, Nagasaka T, Kanazawa S, Koike J, Kikuchi Y, Zhong X, Arita M, Shibuya K, Oshimura M, Hemmi H, Boland CR, Koi M. Genetic instability caused by loss of MutS homologue 3 in human colorectal cancer. Cancer Res 2008, 68:8465-72. 10.1158/0008-5472.CAN-08-0002, 2678948, 18922920.
7. Mukaida N, Kodama S, Suzuki K, Oshimura M, Watanabe M. Transmission of genomic instability from a single irradiated human chromosome to the progeny of unirradiated cells. Radiat Res 2007, 167:675-681. 10.1667/RR0835.1, 17523850.
8. Nguyen P, Cui H, Bisht KS, Sun L, Patel K, Lee RS, Kugoh H, Oshimura M, Feinberg AP, Gius D. CTCFL/BORIS is a methylation-independent DNA-binding protein that preferentially binds to the paternal H19 differentially methylated region. Cancer Res 2008, 68:5546-5551. 10.1158/0008-5472.CAN-08-1005, 2731476, 18632606.
9. Ishihara K, Oshimura M, Nakao M. CTCF-dependent chromatin insulator is linked to epigenetic remodeling. Mol Cell 2006, 23:733-742. 10.1016/j.molcel.2006.08.008, 16949368.
10. Tomizuka K, Yoshida H, Uejima H, Kugoh H, Sato K, Ohguma A, Hayasaka M, Hanaoka K, Oshimura M, Ishida I. Functional expression and germline transmission of a human chromosome fragment in chimaeric mice. Nat Genet 1997, 16:133-143. 10.1038/ng0697-133, 9171824.
11. Doherty AMO, Fisher EMC. Microcell-mediated chromosome transfer (MMCT): small cells with huge potential. Mamm Genome 2003, 14:583-592. 10.1007/s00335-003-4002-0, 14629108.
12. Robl JM, Kasinathan P, Sullivan E, Kuroiwa Y, Tomizuka K, Ishida I. Artificial chromosome vectors and expression of complex proteins in transgenic animals. Theriogenology 2003, 59:107-113. 10.1016/S0093-691X(02)01262-1, 12499022.
13. Shinohara T, Tomizuka K, Miyabara S, Takehara S, Kazuki Y, Inoue J, Katoh M, Nakane H, Iino A, Ohguma A, Ikegami S, Inokuchi K, Ishida I, Reeves RH, Oshimura M. Mice containing a human chromosome 21 model behavioral impairment and cardiac anomalies of Down's syndrome. Hum Mol Genet 2001, 10:1163-1175. 10.1093/hmg/10.11.1163, 11371509.
14. Katoh M, Ayabe F, Norikane S, Okada T, Masumoto H, Horike S, Shirayoshi Y, Oshimura M. Construction of a novel human artificial chromosome vector for gene delivery. Biochem Biophys Res Commun 2004, 321:280-290. 10.1016/j.bbrc.2004.06.145, 15358173.
15. Hoshiya H, Kazuki Y, Abe S, Takiguchi M, Kajitani N, Watanabe Y, Yoshino T, Shirayoshi Y, Higaki K, Messina G, Cossu G, Oshimura M. A highly stable and nonintegrated human artificial chromosome (HAC) containing the 2.4 Mb entire human dystrophin gene. Mol Ther 2009, 17:309-317. 10.1038/mt.2008.253, 2835068, 19034264.
16. Yang J, Shen MH. Polyethylene glycol-mediated cell fusion. Methods Mol Biol 2006, 325:59-66.
17. Wojcieszyn JW, Schlegel RA, Lumley-Sapanski K, Jacobson KA. Studies on the mechanism of polyethylene glycol-mediated cell fusion using fluorescent membrane and cytoplasmic probes. J Cell Biol 1983, 96:151-9. 10.1083/jcb.96.1.151, 2112265, 6826645.
18. Golestani R, Pourfathollah AA, Moazzeni SM. Cephalin as an efficient fusogen in Hybridoma technology: Can it replace poly ethylene glycol?. Hybridoma 2007, 26:296-301. 10.1089/hyb.2007.0510, 17979545.
19. Roos DS, Choppin PW. Biochemical studies on cell fusion. I. Lipid composition of fusion-resistant cells. J Cell Biol 1985, 101:1578-90. 10.1083/jcb.101.4.1578, 2113923, 4044645.
20. Roos DS, Choppin PW. Biochemical studies on cell fusion. II. Control of fusion response by lipid alteration. J Cell Biol 1985, 101:1591-8. 10.1083/jcb.101.4.1591, 2113917, 4044646.
21. Grammatikos SI, Subbaiah PV, Victor TA, Miller WM. Diverse Effects of Essential (N-6 and N-3) Fatty-Acids on Cultured-Cells. Cytotechnology 1994, 15:31-50. 10.1007/BF00762377, 7765945.
22. Navaratnarajah CK, Leonard VHJ, Cattaneo R. Measles Virus Glycoprotein Complex Assembly, Receptor Attachment, and Cell Entry. Curr Top Microbiol Immunol 2009, 329:59-76. full_text, 19198562.
23. Blechacz B, Russell SJ. Measles virus as an oncolytic vector platform. Curr Gene Ther 2008, 8:162-175. 10.2174/156652308784746459, 18537591.
24. Grote D, Russell SJ, Cornu TI, Cattaneo R, Vile R, Poland GA, Fielding AK. Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice. Blood 2001, 97:3746-3754. 10.1182/blood.V97.12.3746, 11389012.
25. Nakamura T, Peng KW, Vongpunsawad S, Harvey M, Mizuguchi H, Hayakawa T, Cattaneo R, Russell SJ. Antibody-targeted cell fusion. Nat Biotech 2004, 22:331-336.
26. Nakamura T, Peng KW, Harvey M, Greiner S, Lorimer IAJ, James CD, Russell SJ. Rescue and propagation of fully retargeted oncolytic measles viruses. Nat Biotech 2005, 23:209-214.
27. Okamoto T, Aoyama T, Nakayama T, Nakamata T, Hosaka T, Nishijo K, Nakamura T, Kiyono T, Toguchida J. Clonal heterogeneity in differentiation potential of immortalized human mesenchymal stem cells. Biochem and Biophys Res Commun 2002, 295:354-361.
28. Anderson BD, Nakamura T, Russell SJ, Peng KW. High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus. Cancer Res 2004, 64:4919-4926. 10.1158/0008-5472.CAN-04-0884, 15256464.
29. Mathis JM, Stoff-Khalili MA, Curiel DT. Oncolytic adenoviruses - selective retargeting to tumor cells. Oncogene 2005, 24:7775-7791. 10.1038/sj.onc.1209044, 16299537.
30. Jaras M, Brun ACM, Karlsson S, Fan XL. Adenoviral vectors for transient gene expression in human primitive hematopoietic cells: Applications and prospects. Exp Hematol 2007, 35:343-349. 10.1016/j.exphem.2006.11.004, 17309814.
31. Buchholz CJ, Muhlebach MD, Cichutek K. Lentiviral vectors with measles virus glycoproteins - dream team for gene transfer?. Trends Biotechnol 2009, 27:259-265. 10.1016/j.tibtech.2009.02.002, 19327858.
32. Schneider U, Bullough F, Vongpunsawad S, Russell SJ, Cattaneo R. Recombinant measles viruses efficiently entering cells through targeted receptors. J Virol 2000, 74:9928-9936. 10.1128/JVI.74.21.9928-9936.2000, 102030, 11024120.
33. Jing YQ, Tong CL, Zhang J, Nakamura T, Iankov I, Russell SJ, Merchan JR. Tumor and Vascular Targeting of a Novel Oncolytic Measles Virus Retargeted against the Urokinase Receptor. Cancer Res 2009, 69:1459-1468. 10.1158/0008-5472.CAN-08-2628, 2739455, 19208845.
34. Ikeno M, Masumoto H, Okazaki T. Distribution of CENP-B boxes reflected in CREST centromere antigenic sites on long-range alpha-satellite DNA arrays of human chromosome 21. Hum Mol Genet 1994, 3:1245-1257. 10.1093/hmg/3.8.1245, 7987298.